CRESEMBA.EU
CRESEMBA EU landing pageThis website drives users to the country-specific web pages.
http://www.cresemba.eu/
This website drives users to the country-specific web pages.
http://www.cresemba.eu/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.4 seconds
PAGES IN
THIS WEBSITE
2
SSL
EXTERNAL LINKS
2
SITE IP
185.53.172.2
LOAD TIME
0.359 sec
SCORE
6.2
CRESEMBA EU landing page | cresemba.eu Reviews
https://cresemba.eu
This website drives users to the country-specific web pages.
cresemba.eu
CRESEMBA EU landing page
http://www.cresemba.eu/rest-of-world.html
You are now leaving the Basilea Pharmaceutica Ltd Web site. Basilea offers the link to the following Internet site as a service to the Internet community and is not responsible for any content published on the Web site you are about to enter. For Drug Ordering, please contact medical.information@basilea.com. For Medical Information, Drug Safety, and Product Complaints, please contact basilea@druginfo.com. Terms of Use and Privacy Policy. Last revised: 14 June 2016.
CRESEMBA EU landing page
http://www.cresemba.eu/other-eu-countries.html
You are now leaving the Basilea Pharmaceutica Ltd Web site. Basilea offers the link to the following Internet site as a service to the Internet community and is not responsible for any content published on the Web site you are about to enter. For Drug Ordering, please contact global@idispharma.com. For Medical Information, Drug Safety, and Product Complaints, please contact basilea@druginfo.com. Terms of Use and Privacy Policy. Last revised: 14 June 2016.
TOTAL PAGES IN THIS WEBSITE
2
Basilea Pharmaceutica - Corporate - Transparence des liens d’intérêt
http://www.basilea.com/Corporate/Transparence-des-liens-dinteret
Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Dr Günter Ditzinger. Dr Josef Künzle. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Transparence des liens d’intérêt. Rsaquo;› go! Transparence des liens d’intérêt / French Sunshine Act. Transparence des liens d’intérêt. Conformément aux dispositions de la loi n 2011-2012 du 29 décembre 2011, et plus particulièrement l’article L. 1453-1 du Code de la santé publique, Basilea est dans l’obligation de rendre publics:. In accord...
Basilea Pharmaceutica - Corporate - Corporate information
http://www.basilea.com/Corporate/Corporate-information
Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Dr Günter Ditzinger. Dr Josef Künzle. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Transparence des liens d’intérêt. Rsaquo;› go! Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through the integrated research, development and commercial operations of its Swiss subsidiary Basilea Pharmaceutica International Ltd., the company focuses on providin...By Basile...
TOTAL LINKS TO THIS WEBSITE
2
Cresemba SMPC
Isavuconazol (Wirkstoff: Isavuconazoniumsulfat) ist ein intravenöses und orales Breitband-Antimykotikum, das in der Europäischen Union (EU) zugelassen ist für die Behandlung von Erwachsenen mit :. Mukormykose bei Patienten, bei denen eine Behandlung mit Amphotericin B nicht angemessen ist. Um weitere Informationen über CRESEMBA zu erhalten, melden Sie sich bitte mit Ihren DocCheck-Zugangsdaten an. Oder per Telefon (0800-298022). Fachinformation. Stand: Oktober 2015.
Registered & Protected by MarkMonitor
This domain is registered and protected. More than half the Fortune 100 trust MarkMonitor. To protect their brands online.
Cresemba SMPC
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Basilea Pharmaceutica. This site is intended for healthcare. In the United Kingdom. You are now leaving the Basilea Medical Ltd Web site. Basilea offers the link to the following Internet site as a service to the Internet community and is not responsible for any content published on the Web site you are about to enter. Or by phone at (UK) 08001413328.
Antifungal Medication | CRESEMBA® (isavuconazonium sulfate)
For US. Healthcare Professionals Only. Is indicated for the treatment of invasive aspergillosis and invasive mucormycosis in adults. Usage. Watch Dr. George Thompson, infectious disease specialist, discuss the clinical efficacy, safety, and dosing regimen for CRESEMBA in the treatment of adult patients with invasive aspergillosis and invasive mucormycosis. Capsules not actual size. Start and stay on. CRESEMBA is available in IV and PO formulations with once-daily maintenance dosing. Coadministration of s...
Cresemba SMPC
Isavuconazol (Wirkstoff: Isavuconazoniumsulfat) ist ein intravenöses und orales Breitband-Antimykotikum, das in der Europäischen Union (EU) zugelassen ist für die Behandlung von Erwachsenen mit :. Mukormykose bei Patienten, bei denen eine Behandlung mit Amphotericin B nicht angemessen ist. Um weitere Informationen über CRESEMBA zu erhalten, melden Sie sich bitte mit Ihren DocCheck-Zugangsdaten an. Eintritt frei für medizinische Fachkreis. Oder per Telefon (0800-1840212).
CRESEMBA EU landing page
This site is intended for healthcare. Professionals outside the US. You are now leaving the Basilea Pharmaceutica Ltd Web site. Basilea offers the link to the following Internet site as a service to the Internet community and is not responsible for any content published on the Web site you are about to enter. Isavuconazole (drug substance: isavuconazonium sulfate) is an intravenous and oral broad-spectrum antifungal licensed in the European Union (EU) for the treatment of adult patients with:.
Cresemba SMPC
Veuillez vous connecter ci-dessous. Avec vos identifiants DocCheck. Accès libre pour les professionnels de la santé. Mot de passe oublié? Mot de passe oublié? Conditions d’utilisation et politique de confidentialité. Date de dernière révision: Juin 2016.
The domain www.cresemba.info is registered by NetNames
The domain name www.cresemba.info. Has been registered by NetNames. Every domain name comes with free web and email forwarding. To forward your domain name to another web page or site, log into your control panel at www.netnames.com. And change the web forwarding settings.
Cresemba SMPC
L'accesso in basso con la vostra password DocCheck. Acceso libero per i professionisti della salute. Termini e Condizioni di Utilizzo. Depositato presso AIFA il 27/07/2016.
The domain www.cresemba.mobi is registered by NetNames
The domain name www.cresemba.mobi. Has been registered by NetNames. Every domain name comes with free web and email forwarding. To forward your domain name to another web page or site, log into your control panel at www.netnames.com. And change the web forwarding settings.
Registered & Protected by MarkMonitor
This domain is registered and protected. More than half the Fortune 100 trust MarkMonitor. To protect their brands online.
